Jeff R. Schroeder
2017
In 2017, Jeff R. Schroeder earned a total compensation of $830.1K as Chief Commercial Officer at Oxford Immunotec Global, a 11% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $104,200 |
---|---|
Option Awards | $241,999 |
Salary | $355,724 |
Stock Awards | $117,950 |
Other | $10,225 |
Total | $830,098 |
Schroeder received $355.7K in salary, accounting for 43% of the total pay in 2017.
Schroeder also received $104.2K in non-equity incentive plan, $242K in option awards, $118K in stock awards and $10.2K in other compensation.
Rankings
In 2017, Jeff R. Schroeder's compensation ranked 9,864th out of 14,666 executives tracked by ExecPay. In other words, Schroeder earned more than 32.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,864 out of 14,666 | 33rd |
Division Manufacturing | 3,815 out of 5,772 | 34th |
Major group Chemicals And Allied Products | 1,328 out of 2,075 | 36th |
Industry group Drugs | 1,074 out of 1,731 | 38th |
Industry In Vitro and In Vivo Diagnostic Substances | 40 out of 72 | 44th |
Source: SEC filing on April 27, 2018.
Schroeder's colleagues
We found two more compensation records of executives who worked with Jeff R. Schroeder at Oxford Immunotec Global in 2017.